Insiders · PDSB

Lars Boesgaard

Chief Financial Officer at PDS Biotechnology Corp (PDSB) since December 2023

Lars Boesgaard has filed 4 insider reports with the SEC since December 2023, as chief Financial Officer at PDS Biotechnology Corp (PDSB). The latest filing, on March 3, 2026, reports grant or award at PDS Biotechnology Corp (PDSB).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where Lars Boesgaard is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
PDS Biotechnology Corp logo
PDSB
PDS Biotechnology Corp
Chief Financial Officersince December 2023$0.7774Mar 3, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Lars Boesgaard with

Other insiders at the same companies

Questions about Lars Boesgaard

What is Lars Boesgaard's role at PDS Biotechnology Corp?
Lars Boesgaard reports to the SEC as chief Financial Officer at PDS Biotechnology Corp (PDSB), according to the latest filing on March 3, 2026.
Has Lars Boesgaard bought or sold stock recently?
No open-market purchases or sales by Lars Boesgaard are on file. The filings report grant or award.
How do I get alerts when Lars Boesgaard files?
Follow Lars Boesgaard on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Lars Boesgaard (SEC CIK 0001403893). Totals count each trade once, skipping amendments whose original is on file, from Dec 4, 2023 on. View on SEC EDGAR · Get this as JSON